The management of pregnant women with antiphospholipid syndrome;Leczenie zespołu antyfosfolipidowego w cia̧ży

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue SUPPL., 2007, Pages 50-53

  Skrzypczak, Jana ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antiphospholipid syndrome; Aspirin; Heparins; Miscarriage; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN DERIVATIVE; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN; STEROID;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG MECHANISM; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLASMAPHERESIS; PREECLAMPSIA; PREGNANCY; SOLUTIO PLACENTAE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 36549043424     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Cervera R, Balasch J. The management of pregnant patients with antiphospholipid syndrome. Lupus. 2004; 13: 683-687.
2. Salomon JE, Girardi G, Lockshin MD. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Natural Clinical Practice Rheumatology. 2007; 3: 140-147.
3. Tincani A, Bmach W, Levy RA, et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus. 2003; 12: 524-529.
4. Pattison NS, Chamley LW, Birdsall M, et al. Does aspirin have a role in improving pregnancy outcome for women with the anthiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol. 2000; 183: 1008-1012.
5. Stone S, Langford K, Nelson-Piercy C, et al. Antiphospholipid antibodies do not a syndrome make. Lupus. 2002; 11: 130-133.
6. Ruiz-Irastorza G, Khamashta MA. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann NY Acad Sci. 2005; 1051: 606-612.
7. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol. 1989; 160: 439-443.
8. Conwchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-does heparin treatment. Am J Obstet Gynecol. 1992; 166: 1318-1323.
9. Branch DW, Peaceman AM, Druzin M, et al. A mutticenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol. 2000; 182: 122-127.
10. Vaquera E, Lazzarin N, Valensise H, et al. Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: A comparatives study of intravenous immunoglobulin versus prednisone plus low-doses aspirin. Am J Reprod Immunol. 2001; 45: 174-179.
11. Ruffatti A, Marson P, Pengo V, et al. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmunity Rev. 2007; 6: 196-202.